Pre-exposure prophylaxis (PrEP) to prevent HIV in men who have sex with men (MSM) has achieved significant reductions in HIV transmission. But has PrEP become one of the key drivers of the epidemic of sexually transmitted infections currently affecting this vulnerable population? Has decreased fear of contracting HIV also decreased condom use? What’s being done to slow the acquisition and transmission of gonorrhea, syphilis, and chlamydia among MSM on PrEP? What does the evidence say?
Those are some of the questions Dr. Matthew Spinelli, assistant professor in the Department of HIV, ID, and Global Medicine at the University of California San Francisco, addresses in this issue of eHIV Review.
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: August 27, 2020
Expiration date: August 26, 2022